What this deck covers
This deck focuses on Pharmaceutics, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Pharmaceutics in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
What is the definition of isotonicity for a pharmaceutical solution relative to blood/tears?
Tap card or press Space to flip
Same osmotic pressure as blood/tears; no net water movement. Ensures osmotic equilibrium with physiological fluids, preventing cellular dehydration or swelling upon administration.
How well did you know it?
Card 1 / 24
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Pharmaceutics, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Same osmotic pressure as blood/tears; no net water movement. Ensures osmotic equilibrium with physiological fluids, preventing cellular dehydration or swelling upon administration.
Answer: pH=pKa+log([HA][A−]). Describes the relationship between pH and the ionization state of a weak acid, where the log ratio of conjugate base to acid shifts the equilibrium.
Answer: HLBmix=f1HLB1+f2HLB2. Provides a weighted average to achieve the optimal HLB for stabilizing a specific emulsion by blending surfactants.
Answer: %ionized=1+10(pKa−pH)100. Derived from the Henderson-Hasselbalch equation, quantifies the proportion of ionized weak acid molecules based on the pH-pKa difference.
Answer: Maintain pH to optimize stability, solubility, and patient acceptability. Resists pH changes from external factors, ensuring consistent drug properties and tolerability in the formulation.
Answer: Hydrophilic–lipophilic balance; higher HLB indicates more hydrophilic surfactant. Quantifies surfactant polarity to match emulsion type, with higher values favoring oil-in-water systems for better stability.
Answer: Free of viable microorganisms (bacteria, fungi, and spores). Ensures absence of living microbes to prevent infection, critical for parenteral and ophthalmic preparations.
Answer: F=AUCivAUCpo×DosepoDoseiv. Compares the systemic exposure from oral dosing to intravenous, adjusted for dose differences, to determine absorption efficiency.
Answer: %ionized=1+10(pH−pKa)100. Derived from the Henderson-Hasselbalch equation, quantifies the proportion of ionized weak base molecules based on the pH-pKa difference.
Answer: Water-in-oil (W/O). Lower HLB surfactants preferentially stabilize water droplets in oily continuous phase due to greater oil affinity.
Answer: Oil-in-water (O/W). Higher HLB surfactants preferentially stabilize oil droplets in aqueous continuous phase due to greater water affinity.
Answer: Two immiscible liquids with one dispersed in the other, stabilized by emulsifier. Enables delivery of immiscible phases by reducing interfacial tension and preventing coalescence through emulsifier stabilization.
Answer: Decreasing particle size (increases surface area A). Smaller particles provide greater surface area for solvent interaction, accelerating the dissolution process per the Noyes-Whitney equation.
Answer: Agent added to inhibit microbial growth during storage and use. Prevents contamination and spoilage in products susceptible to repeated exposure, extending shelf life and safety.
Answer: Insoluble solid particles dispersed in a liquid vehicle. Provides a heterogeneous system for poorly soluble drugs, allowing uniform dosing upon shaking for even particle distribution.
Answer: Flocculated: fast settling, easy resuspension; deflocculated: slow, caking risk. Flocculation forms loose aggregates that settle quickly but redisperse easily, while deflocculation leads to compact sediments prone to hardening.
Answer: pH<pKa. At lower pH, the environment favors the protonated, unionized form of the weak acid, enhancing lipid solubility and membrane permeation.
Answer: pH=pKa+log([BH+][B]). Describes the relationship between pH and the ionization state of a weak base, where the log ratio of base to conjugate acid shifts the equilibrium.
Answer: Fraction of administered dose reaching systemic circulation unchanged. Quantifies the extent of drug absorption into the bloodstream without alteration, critical for assessing oral versus intravenous efficacy.
Answer: pH>pKa. At higher pH, the environment favors the deprotonated, unionized form of the weak base, enhancing lipid solubility and membrane permeation.
Answer: pH where ionized and unionized forms are equal (50% each). Represents the equilibrium point where half the molecules are protonated and half deprotonated, indicating equal concentrations of ionized and unionized forms.
Answer: dtdC=hDA(Cs−C). Models the rate of drug dissolution as proportional to the diffusion coefficient, surface area, and concentration gradient across the boundary layer.
Answer: Inactive/less active form converted in vivo to active drug. Allows for improved pharmacokinetics, such as enhanced solubility or targeted activation, by metabolic conversion to the therapeutic moiety.
Answer: Osmolarity: Osm/L; osmolality: Osm/kg (water). Osmolarity measures solute concentration per liter of solution, while osmolality measures per kilogram of solvent, accounting for temperature-independent properties.